Amoy Diagnostics Co Ltd (300685) - Total Liabilities

Latest as of June 2026: CN¥320.47 Million CNY ≈ $46.90 Million USD

Based on the latest financial reports, Amoy Diagnostics Co Ltd (300685) has total liabilities worth CN¥320.47 Million CNY (≈ $46.90 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Amoy Diagnostics Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Amoy Diagnostics Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Amoy Diagnostics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Amoy Diagnostics Co Ltd balance sheet assets.

Amoy Diagnostics Co Ltd Competitors by Total Liabilities

The table below lists competitors of Amoy Diagnostics Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhejiang Taihua New Material SHG:603055	China	CN¥6.05 Billion
FGV Holdings Bhd KLSE:5222	Malaysia	RM11.34 Billion
U-Haul Holding Company NYSE:UHAL	USA	$13.87 Billion
Nationwide Building Society LSE:NBS	UK	£358.92 Billion
OMH SCIENCE Group Co Ltd SHE:300486	China	CN¥1.38 Billion
Elemental Royalties Corp V:ELE	Canada	CA$126.90 Million
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥379.82 Million
Xpel Inc NASDAQ:XPEL	USA	$113.84 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Amoy Diagnostics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300685 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amoy Diagnostics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amoy Diagnostics Co Ltd (2012–2025)

The table below shows the annual total liabilities of Amoy Diagnostics Co Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥291.69 Million ≈ $42.68 Million	+31.67%
2024-12-31	CN¥221.54 Million ≈ $32.42 Million	-4.33%
2023-12-31	CN¥231.56 Million ≈ $33.88 Million	+53.15%
2022-12-31	CN¥151.20 Million ≈ $22.12 Million	+0.63%
2021-12-31	CN¥150.25 Million ≈ $21.99 Million	-8.61%
2020-12-31	CN¥164.41 Million ≈ $24.06 Million	+13.64%
2019-12-31	CN¥144.67 Million ≈ $21.17 Million	+133.31%
2018-12-31	CN¥62.01 Million ≈ $9.07 Million	+35.84%
2017-12-31	CN¥45.65 Million ≈ $6.68 Million	+0.55%
2016-12-31	CN¥45.39 Million ≈ $6.64 Million	-16.78%
2015-12-31	CN¥54.55 Million ≈ $7.98 Million	-38.65%
2014-12-31	CN¥88.90 Million ≈ $13.01 Million	+25.13%
2013-12-31	CN¥71.05 Million ≈ $10.40 Million	+43.24%
2012-12-31	CN¥49.60 Million ≈ $7.26 Million	--

About Amoy Diagnostics Co Ltd

SHE:300685 China Diagnostics & Research

Market Cap

$1.19 Billion

CN¥8.13 Billion CNY

Market Cap Rank

#8112 Global

#1856 in China

Share Price

CN¥20.85

Change (1 day)

+0.19%

52-Week Range

CN¥16.18 - CN¥23.82

All Time High

CN¥57.70